Can a pill target multiple Hard-to-Treat cancers?
Disease control
Recruiting now
This early-stage trial tests an experimental pill called JBI-778 in people with certain advanced cancers: EGFR-mutated lung cancer (with or without brain metastases), recurrent high-grade glioma, or adenoid cystic carcinoma. The drug is designed to block a protein that helps canc…
Phase: PHASE1 • Sponsor: Jubilant Therapeutics India Limited • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC